A diverse range of human gut bacteria have the potential to metabolize the dietary component gallic acid

Loading...
Thumbnail Image
Files
e01558-18.full.pdf(2.31 MB)
Published Version
zam019188781s1.pdf(295.53 KB)
Supplemental File 1
Date
2018-07-27
Authors
Esteban-Torres, María
Santamaría, Laura
Cabrera-Rubio, Raul
Plaza-Vinuesa, Laura
Crispie, Fiona
de las Rivas, Blanca
Cotter, Paul D.
Muñoz, Rosario
Journal Title
Journal ISSN
Volume Title
Publisher
American Society for Microbiology
Published Version
Research Projects
Organizational Units
Journal Issue
Abstract
The human gut microbiota contains a broad variety of bacteria that possess functional genes, with resultant metabolites that affect human physiology and therefore health. Dietary gallates are phenolic components that are present in many foods and beverages and are regarded as having health-promoting attributes. However, the potential for metabolism of these phenolic compounds by the human microbiota remains largely unknown. The emergence of high-throughput sequencing (HTS) technologies allows this issue to be addressed. In this study, HTS was used to assess the incidence of gallate-decarboxylating bacteria within the gut microbiota of healthy individuals for whom bacterial diversity was previously determined to be high. This process was facilitated by the design and application of degenerate PCR primers to amplify a region encoding the catalytic C subunit of gallate decarboxylase (LpdC) from total metagenomic DNA extracted from human fecal samples. HTS resulted in the generation of a total of 3,261,967 sequence reads and revealed that the primary gallate-decarboxylating microbial phyla in the intestinal microbiota were Firmicutes (74.6%), Proteobacteria (17.6%), and Actinobacteria (7.8%). These reads corresponded to 53 genera, i.e., 47% of the bacterial genera detected previously in these samples. Among these genera, Anaerostipes and Klebsiella accounted for the majority of reads (40%). The usefulness of the HTS-lpdC method was demonstrated by the production of pyrogallol from gallic acid, as expected for functional gallate decarboxylases, among representative strains belonging to species identified in the human gut microbiota by this method. Importance: Despite the increasing wealth of sequencing data, the health contributions of many bacteria found in the human gut microbiota have yet to be elucidated. This study applies a novel experimental approach to predict the ability of gut microbes to carry out a specific metabolic activity, i.e., gallate metabolism. The study showed that, while gallate-decarboxylating bacteria represented 47% of the bacterial genera detected previously in the same human fecal samples, no gallate decarboxylase homologs were identified from representatives of Bacteroidetes. The presence of functional gallate decarboxylases was demonstrated in representative Proteobacteria and Firmicutes strains from the human microbiota, an observation that could be of considerable relevance to the in vivo production of pyrogallol, a physiologically important bioactive compound.
Description
Keywords
HTS , Antioxidant , Human intestinal tract , Microbiota , Phenolic compounds , Pyrogallol
Citation
Esteban-Torres, M., Santamaría, L., Cabrera-Rubio, R., Plaza-Vinuesa, L., Crispie, F., de las Rivas, B., Cotter, P. and Muñoz, R. (2018) 'A diverse range of human gut bacteria have the potential to metabolize the dietary component gallic acid', Applied and Environmental Microbiology, 84(19), e01558-18 (12pp). doi:10.1128/aem.01558-18
Copyright
© 2018, American Society for Microbiology. All rights reserved.